Skip to content

GDPoster

Paclitaxel in PAD Warnings Echo Past Drug-Eluting Stent Scare…………

    Paclitaxel-coated balloons and stents were the standard of care for interventions in the superficial femoral and popliteal arteries. Then in December 2018, a meta-analysis from Greece by Katsanos and colleagues suggested an increased risk for late mortality with the paclitaxel-coated devices versus uncoated devices. This led the US Food and Drug Administration (FDA) to do a… Read More »Paclitaxel in PAD Warnings Echo Past Drug-Eluting Stent Scare…………

    GDMEDS STRENGTHENS THE TEAM OF CHEMIST/PHARMACIST TO SERVE BETTER…..

      With rising health care costs and the advent of consumer-driven health care, consumers now take a more active role in the health care process and their health care decisions. Smart consumers look for medical providers and health care centers that offer comprehensive health services. Pharmacies and medical retail clinics, and the retail pharmacists serve as… Read More »GDMEDS STRENGTHENS THE TEAM OF CHEMIST/PHARMACIST TO SERVE BETTER…..

      THANKS GOOGLE TRANSLATORS…….

        Thanks, Google translator Gracias traductor de google Merci, traducteur Google 谢谢,谷歌翻译 マイレビュー спасибо, гугл-переводчик 감사,구글 번역기 cảm ơn, google translator danke, google übersetzer GDMeds leading online pharmaceutical company has a support hand ofGoogle translators for their well growth in their business. Google translators are a free multilingual machine translation service developed byGoogle, to translate text.… Read More »THANKS GOOGLE TRANSLATORS…….

        GDMEDS OPENING SHORTLY CUSTOMER SERVICE CENTRE IN GODS OWN COUNTRY- KERALA.

          GDMeds one of the leading online pharmacy has released fantastic news as they are going to build up their strength in Kerala. GDMeds was started by the intention of Dr.Liya and Vincent Cooper to help patients purchase reliable and cheap generic anti-cancer medicines since 2014, they started up their business as a ground level business… Read More »GDMEDS OPENING SHORTLY CUSTOMER SERVICE CENTRE IN GODS OWN COUNTRY- KERALA.

          FDA Approves Two-Drug Combo Mavyret for HCV in Adolescents.

            The US Food and Drug Administration (FDA) approved glecaprevir and pibrentasvir (Mavyret, AbbVie) tablets for the treatment of all six hepatitis C virus (HCV) genotypes in children ages 12 to 17 years. The FDA approved the drug combination for adults with all six genotypes of hepatitis C on Aug. 3, 2017. “Direct-acting antiviral drugs reduce the amount of HCV in the… Read More »FDA Approves Two-Drug Combo Mavyret for HCV in Adolescents.